Real-Time Cell Cycle Imaging in a 3D Cell Culture Model of Melanoma.

Aberrant cell cycle progression is a hallmark of solid tumors; therefore, cell cycle analysis is an invaluable technique to study cancer cell biology. However, cell cycle progression has been most commonly assessed by methods that are limited to temporal snapshots or that lack spatial information. Here, we describe a technique that allows spatiotemporal real-time tracking of cell cycle progression of individual cells in a multicellular context. The power of this system lies in the use of 3D melanoma spheroids generated from melanoma cells engineered with the fluorescent ubiquitination-based cell cycle indicator (FUCCI). This technique allows us to gain further and more detailed insight into several relevant aspects of solid cancer cell biology, such as tumor growth, proliferation, invasion, and drug sensitivity.

[1]  N. Haass,et al.  Melanoma's connections to the tumour microenvironment. , 2013, Pathology.

[2]  Eric Brown,et al.  Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion. , 2005, The American journal of pathology.

[3]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[4]  N. Haass.  Dynamic tumor heterogeneity in melanoma therapy: how do we address this in a novel model system? , 2015, Melanoma management.

[5]  N. Haass,et al.  Real‐time cell cycle imaging during melanoma growth, invasion, and drug response , 2014, Pigment cell & melanoma research.

[6]  M. Herlyn,et al.  Melanoma and the tumor microenvironment , 2008, Current oncology reports.

[7]  M. Herlyn,et al.  The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor AZD6244 (ARRY-142886) Induces Growth Arrest in Melanoma Cells and Tumor Regression When Combined with Docetaxel , 2008, Clinical Cancer Research.

[8]  Urs Utzinger,et al.  In vitro model for endogenous optical signatures of collagen. , 2006, Journal of biomedical optics.

[9]  M. Herlyn,et al.  In vitro three-dimensional tumor microenvironment models for anticancer drug discovery , 2008, Expert opinion on drug discovery.

[10]  A. Santiago-Walker,et al.  Melanocytes: From Morphology to Application , 2009, Skin Pharmacology and Physiology.

[11]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[12]  H P Soyer,et al.  A stress-induced early innate response causes multidrug tolerance in melanoma , 2014, Oncogene.

[13]  L. Ng,et al.  A quantitative approach to histopathological dissection of elastin‐related disorders using multiphoton microscopy , 2013, The British journal of dermatology.

[14]  Wolfgang Weninger,et al.  Cell Cycle Phase-Specific Drug Resistance as an Escape Mechanism of Melanoma Cells. , 2016, The Journal of investigative dermatology.

[15]  P. Hersey,et al.  The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance. , 2013, Carcinogenesis.

[16]  Nikolas K. Haass,et al.  Modeling Melanoma In Vitro and In Vivo , 2013, Healthcare.

[17]  M. Herlyn,et al.  Fibroblast‐dependent differentiation of human microvascular endothelial cells into capillary‐like, three‐dimensional networks , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  Atsushi Miyawaki,et al.  Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression , 2008, Cell.

[19]  Farzana Ahmed,et al.  Imaging- and Flow Cytometry-based Analysis of Cell Position and the Cell Cycle in 3D Melanoma Spheroids. , 2015, Journal of visualized experiments : JoVE.

[20]  M. Herlyn,et al.  Fibroblasts contribute to melanoma tumor growth and drug resistance. , 2011, Molecular pharmaceutics.

[21]  Stephan Saalfeld,et al.  Globally optimal stitching of tiled 3D microscopic image acquisitions , 2009, Bioinform..